Antibody responses to the herpes simplex virus type 2 glycoprotein G in sera of human immunodeficiency virus-infected patients in Slovakia

Acta Virologica

Volumn 42, Issue 5, 1998, Pages 319-324

  Bystricka M ^a   Solarikova L ^a   Gasparikova L ^a   Stanekova D ^b   Mokras M ^c   Kovacova E ^a   Sabo A ^a   Russ, G ^a  

^a INSTITUTE OF VIROLOGY   (Slovakia)

^b INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

^c Clinic of Infectious Diseases   (Slovakia)

Author keywords

Antibodies; ELISA; Glycoprotein G 2; Herpes simplex virus type 2; Human immunodeficiency virus; Human sera; Immunoblot analysis

Indexed keywords

ANTIVIRUS AGENT; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; RISK FACTOR; SLOVAKIA; VERO CELL; VIRUS TRANSMISSION;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; CERCOPITHECUS AETHIOPS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; IMMUNOBLOTTING; MALE; SLOVAKIA; VERO CELLS; VIRAL ENVELOPE PROTEINS;

EID: 0032462635     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ashley RL, Militoni J, Lee F, Nahmias A, Corey L (1988): Comparison of Western blot (Immunoblot) and glycoprotein G-specific inimunodot enzyme assay for detecting antibodies to Herpes simplex virus types 1 and 2 in human sera. J. Clin. Microbiol. 26, 662-667.
2. Bergstrom T, Trybala E (1996): Antigenic differences between HSV-1 and HSV-2 glycoproteins and their importance for type-specific serology. Intervirology 39, 176-184.
3. Bystrická M, Vančiková M, Kasalová M, Rajčáni J, Košfál M, Murányiová M, Poláková K, RUSS G (1991): Type-common and type-specific monoclonal antibodies to herpes simplex virus types 1 and 2. Acta Virol. 35, 152-164.
4. Dada AJ, Diamondstone L, Quinn TC, Blattner WA, Biggar RJ (1998): A serosurvey of Haemophilus ducreyi, syphilis, and Herpes simplex virus type 2 and their association with human immunodeficiency virus among female sex workers in Lagos, Nigeria. Sex. Trans. Dis. 25, 237-242.
5. Eberle R, Mou SW (1983): Relative titers of antibodies to individual polypeptide antigens of Herpes simplex virus type 1 in human sera. J. Infect. Dis. 148, 436-444.
6. Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral SO, Lee FK, St. Louis ME (1997): Herpes simplex virus type 2 in the United States, 1976 to 1994. N. Engl. J. Med. 337, 1105-1111.
7. Forsgren M, Skoog E, Jeansson S, Olofsson S, Giesecke J (1994): Prevalence of antibodies to Herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: implications for STD epidemiology. Int. J. STD & AIDS 5, 113-116.
8. Griffiths PD (1998): Studies of viral co-factors for human immunodeficiency virus in vitro and in vivo. J. Gen. Virol. 79, 213-220.
9. Hashido M, Lee FK, Inouye S, Kawana T (1997): Detection of Herpes simplex virus type-specific antibodies by an enzyme-linked immunosorbent assay based on glycoprotein G. J. Med. Virol 53, 319-323.
10. Halbert SP, Kiefer DJ, Friedman-Kien AE, Poiesz B (1986): Antibody levels for Cytomegalovirus, Herpes simplex virus, and Rubella in patients with acquired immune deficiency syndrome. Clin. Microbiol. 23, 318-321.
11. Ho DWT, Field PR, Sjogren-Jansson E, Jeansson S, Cunnigham AL (1992): Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG-2). J. Virol. Methods 36, 249-264.
12. Holmberg SD, Stewart JA, Gerber AR, Byers RH, Lee FK, O'Malley PM, Nahmias AJ (1988): Prior Herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA 259, 1048-1050.
13. Hook EW, Cannon RO, Nahmias AJ (1992): Herpes simplex virus infection as a risk factor for Human immunodeficiency virus infection in heterosexuals. J. Infect. Dis. 165, 251-255.
14. Kingsley LA, Armstrong J, Rahman A, Ho M, Rinaldo CR (1990): No association between Herpes simplex virus type-2 scropositivity or anogenital lesions and HIV seroconversion among homosexual men. J. Acq. Immune Def. Syn. 3, 773-779.
15. Koutsky LA, Ashley RL, Holmes KK, Stevens CE, Critchlow CW, Kiviat N, Lipinski CM, Wolner-Hanssen P, Corey L (1990): The frequency of unrecognized type 2 Herpes simplex virus infection among women. Sex. Trans. Dis. 17, 90-94.
16. Langenberg AGM, Burke RL, Adair SF, Sekulovich R, Tigges M, Dekker CL, Corey L (1995): A recombinant glycoprotein vaccine for Herpes simplex type 2: Safety and efficacy. Ann. Intern. Med. 122, 889-898.
17. Langenberg A, Benedetti J, Jenkins J, Ashley R, Winter C, Corey L (1989): Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" Herpes simplex type 2 infection. Ann. Intern. Med. 110, 882-887.
18. Liljequist JA, Trybala E, Svennerholm B, Jeansson S, Sjogren-Jansson, Bergstrom T (1998): Localization of type-specific epitopes of Herpes simplex virus type 2 glycoprotein G recognized by human and mouse antibodies. J. Gen. Virol. 79, 1215-1224.
19. Safrin S, Arvin A, Mills J, Ashley R (1992): Comparison of the Western immunoblot assay and a glycoprotein G enzyme immunoassay for detection of serum antibodies to Herpes simplex virus type 2 in patients with AIDS. J. Clin. Microbiol. 30, 1312-1314.
20. Sacks SL, Aoki FY, Diaz-Mitoma F, Sellors J, Shafran SD (1996): Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes: a randomized, double-blind multicenter trial. JAMA 276, 44-49.
21. Schacker T, Ryncarz AJ, Goddard J, Diem K, Shaughnessy M, Corey L (1998): Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-l-infected men. Dermatology 194, 93-97.
22. Straus SE, Corey L, Burke RL, Savarese B, Barnum G, Krause PR, Kost RG Meier JL, Sekulovich R, Adair SF, Dekker CL (1994): Placebo-controlled trial of vaccination with recombinant glycoprotein D of Herpes simplex virus type 2 for immunotherapy of genital herpes. Lancet 343, 1460-1463.
23. Wald A, Zeh J, Barnum G, Davis LG, Corey L (1996): Suppression of subclinical shedding of Herpes simplex virus type 2 with acyclovir. Ann. Intern. Med. 124, 8-15.
24. Wasserheit JN (1992): Epidemiological synergy: interrelationhips between human immunodeficiency virus infection and other sexually transmitted diseases. Sex. Trans. Dis. 19, 61-77.